ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.68
0.56%
US Tech 100
18,349.20
1.12%
S&P 500
5,309.31
0.79%
US Dollar vs CAD
1.36579
-0.55%
Bitcoin
68,070.03
0.21%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Adial Pharmaceuticals Inc (ADILW)

  7. Adial Pharmaceuticals Inc (ADILW) News

ADILW

Adial Pharmaceuticals (ADILW)

Adial Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ADILW
DateTimeSourceHeadlineSymbolCompany
05/15/20247:30AMGlobeNewswire Inc.Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:ADILWAdial Pharmaceuticals Inc
04/22/20247:30AMGlobeNewswire Inc.Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark OfficeNASDAQ:ADILWAdial Pharmaceuticals Inc
04/10/20247:30AMGlobeNewswire Inc.Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use DisorderNASDAQ:ADILWAdial Pharmaceuticals Inc
04/02/20247:30AMGlobeNewswire Inc.Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business UpdateNASDAQ:ADILWAdial Pharmaceuticals Inc
03/01/20246:00PMGlobeNewswire Inc.Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross ProceedsNASDAQ:ADILWAdial Pharmaceuticals Inc
02/28/20248:30AMGlobeNewswire Inc.Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark OfficeNASDAQ:ADILWAdial Pharmaceuticals Inc
02/13/20248:15AMGlobeNewswire Inc.Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark OfficeNASDAQ:ADILWAdial Pharmaceuticals Inc
01/18/20247:30AMGlobeNewswire Inc.Adial Announces Appointment of Tony Goodman as Chief Operating OfficerNASDAQ:ADILWAdial Pharmaceuticals Inc
12/20/20238:00AMGlobeNewswire Inc.Adial Pharmaceuticals Receives Final Reimbursement Payment from AdovateNASDAQ:ADILWAdial Pharmaceuticals Inc
11/29/20233:05PMGlobeNewswire Inc.Adial Pharmaceuticals Regains Compliance with Nasdaq Listing RequirementNASDAQ:ADILWAdial Pharmaceuticals Inc
11/14/20234:02PMGlobeNewswire Inc.Adial Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ADILWAdial Pharmaceuticals Inc
10/31/20237:30AMGlobeNewswire Inc.Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss “New Aspects in Substance Use Treatment” at The Annual International Society of Addiction Medicine ConferenceNASDAQ:ADILWAdial Pharmaceuticals Inc
10/25/20237:00AMGlobeNewswire Inc.Addiction Experts Highlight the Need for Non-Abstinence-Based Therapies to Treat Alcohol Use Disorder in Adial Pharmaceuticals Key Opinion Leader WebinarNASDAQ:ADILWAdial Pharmaceuticals Inc
10/24/20233:30PMGlobeNewswire Inc.Adial Pharmaceuticals Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq RulesNASDAQ:ADILWAdial Pharmaceuticals Inc
10/20/20237:00AMGlobeNewswire Inc.Adial Pharmaceuticals Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq RulesNASDAQ:ADILWAdial Pharmaceuticals Inc
10/19/20239:30AMGlobeNewswire Inc.Adial Pharmaceuticals Awarded Notice of Allowance for Key Patent Combining Use of the Company’s Proprietary Genetic Diagnostic with AD04 to Treat Alcohol and Drug DependenceNASDAQ:ADILWAdial Pharmaceuticals Inc
10/18/20237:00AMGlobeNewswire Inc.Adial Pharmaceuticals Wins Frost & Sullivan's 2023 North American Precision Medicine for Addiction Disorders Technology Innovation Leadership AwardNASDAQ:ADILWAdial Pharmaceuticals Inc
09/28/20236:00AMGlobeNewswire Inc.Adial Pharmaceuticals to Host a Virtual Key Opinion Leader Webinar to Discuss the Unmet Need in Alcohol Use DisorderNASDAQ:ADILWAdial Pharmaceuticals Inc
09/05/20237:30AMGlobeNewswire Inc.Adial Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:ADILWAdial Pharmaceuticals Inc
08/28/20237:30AMGlobeNewswire Inc.Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss the Need for New Alcohol Use Disorder Treatments at the European Society for Biomedical Research on AlcoholismNASDAQ:ADILWAdial Pharmaceuticals Inc
08/23/20237:30AMGlobeNewswire Inc.Adial Pharmaceuticals Regains Compliance with Nasdaq Listing RequirementsNASDAQ:ADILWAdial Pharmaceuticals Inc
08/21/20237:30AMGlobeNewswire Inc.Adial Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ADILWAdial Pharmaceuticals Inc
08/04/20237:30AMGlobeNewswire Inc.Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement and Reduce the Public FloatNASDAQ:ADILWAdial Pharmaceuticals Inc
07/11/20237:30AMGlobeNewswire Inc.Adial Provides Business Update Following Favorable Comments from US and EU Regulatory MeetingsNASDAQ:ADILWAdial Pharmaceuticals Inc
06/01/20238:00AMGlobeNewswire Inc.Adial Pharmaceuticals to Present at the 2023 Jefferies Global Healthcare Conference on June 9thNASDAQ:ADILWAdial Pharmaceuticals Inc
05/12/20237:30AMGlobeNewswire Inc.Adial Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ADILWAdial Pharmaceuticals Inc
05/10/20237:30AMGlobeNewswire Inc.Adial Pharmaceuticals Receives Notice of Exercise from Adovate for the Acquisition of Purnovate’s Assets and BusinessNASDAQ:ADILWAdial Pharmaceuticals Inc
03/30/20233:05PMGlobeNewswire Inc.Adial Pharmaceuticals Reports 2022 Fiscal Year Financial Results and Provides Business UpdateNASDAQ:ADILWAdial Pharmaceuticals Inc
03/21/20238:00AMGlobeNewswire Inc.Adial Pharmaceuticals Engages The Keswick Group to Advance Partnering Activities for the Clinical Development of AD04 for Alcohol Use DisorderNASDAQ:ADILWAdial Pharmaceuticals Inc
03/08/20238:00AMGlobeNewswire Inc.Adial Pharmaceuticals to Present at the 35th Annual Roth Conference on March 14thNASDAQ:ADILWAdial Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ADILW

Your Recent History

USOTC
TXTM
ProText Mobility (PK)
USOTC
DPLS
DarkPulse (PK)
NASDAQ
IOVA
Iovance Biotherapeutics
USOTC
AABB
Asia Broadband (PK)
USOTC
AHRO
Authentic (CE)
USOTC
UBQU
Ubiquitech Software (PK)
USOTC
CATV
4Cable TV (PK)
USOTC
SHMP
NaturalShrimp (QB)
NASDAQ
NB
NioCorp Developments
AMEX
SPY
SPDR S&P 500
USOTC
NLST
Netlist (QB)
USOTC
CLNV
Clean Vision (QB)
USOTC
TDRK
TideRock Companies (PK)
NASDAQ
RVNC
Revance Therapeutics
USOTC
VXIT
Virexit Technologies (PK)
USOTC
ERHE
ERHC Energy (CE)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved